Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.
April 3, 2015
In response to a letter signed by 14 State Attorneys General requesting a Congressional inquiry into the herbal supplements industry, the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, issued the following statement:
Statement by Steve Mister, president and CEO, CRN:
“It is unfortunate that the New York State Attorney General (NY AG) has spearheaded a request for Congress to spend taxpayers’ money to ‘launch a comprehensive congressional inquiry into the herbal supplements industry’ when the industry is already amply regulated on a federal level by FDA and FTC. In fact, concerns raised in that letter about alleged widespread safety issues are not true, based on government’s post-market surveillance system which demonstrates relatively few safety issues for these products, particularly in comparison to other industries regulated by FDA.
"The ‘serious concerns’ raised in the letter to Congress are based on an initial investigation from the NY AG which has been roundly criticized and discredited not only by industry scientists, but also by critics of the herbal supplements industry, as well as by a number of journalists. Further, the NY AG has refused to release the details of the findings from his investigation, demonstrating a disturbing lack of transparency, and making it impossible for scientific experts to answer with certainty—although there are plausible theories—as to why some of the products tested contained allergens and plant species left off the label. What is certain is that the basis of the report—a testing methodology known as DNA Barcoding—is simply an inappropriate methodology for testing herbal supplements made from herbal extracts, thereby making the NY AG’s report misleading. Despite these considerable doubts, the NY AG refuses to share his test results and methodology with FDA, with the media who continue to report on this story, with the companies implicated in those results, or even with the other state AGs he has persuaded to join in his campaign. In fact, an agreement between the NY AG and one of these companies earlier in the week explicitly stated that there were no issues with the herbal supplements being investigated, and because of this, the products were returned to the store shelves.
"Over the past month, CRN has met with a number of state AGs around the country, and we are gratified that the concerns go away once we’re given the opportunity to fully explain the issue. Herbal supplements are regulated by FDA as a category of food and substantial regulations are in place for pre-market notification of new ingredients, good manufacturing practices (including identity testing of both raw materials and finished products), product labeling and post-market surveillance (i.e., mandatory reporting of any serious adverse events associated with these products). CRN is a strong and vocal advocate for more resources to FDA for stronger and swifter enforcement of these existing regulations. We acknowledge there are some problems facing our industry, and we wish that the state AGs had focused their efforts on helping solve the serious problem of criminals who spike products with illegal drugs and market them illegally as dietary supplements.
"On behalf of our member companies, our association will certainly cooperate and answer any questions Congress may have about our industry as we share the common goal of making sure that consumers have access to the safe and beneficial herbal supplement products they use to improve their health and well-being.”
The Council for Responsible Nutrition (CRN), a Washington, D.C.-based national trade association for the dietary supplement industry, is a monthly contributor to the NewHope360.com blog. CRN’s thought-provoking commentary looks at issues impacting the dietary supplement industry and offers perspectives for addressing these issues.
Steve Mister Esq., President and CEO
Judy Blatman, Senior Vice President of Communications
John Hathcock, Ph.D., Senior Vice President of Scientific and International Affairs
Douglas “Duffy” MacKay, N.D., Vice President of Scientific and Regulatory Affairs
Mike Greene, Vice President of Government Relations
You May Also Like
NCN report analyzes investment slowdown, explores opportunitiesMar 2, 2024
Free AF launches AF Sparkling Rosé with Afterglow™ – press releaseMar 1, 2024
Top Trends at Expo West 2024 – slideshowMar 1, 2024
Natural Products Expo West offers investors a wealth of eventsMar 1, 2024